PT-141 peptide capsules are an unapproved oral form of bremelanotide. Learn how capsules compare to the injection, reported dosing, cost, and safety risks.
PT-141 peptide capsules are an oral, unapproved form of bremelanotide, a melanocortin receptor agonist studied for sexual desire. The only FDA-approved version of this drug is a subcutaneous injection sold under the brand name Vyleesi, and no oral capsule product has been reviewed or cleared for human use in the United States. Capsules sold online are generally labeled as research chemicals, which means their purity, dose, and safety are not verified by any regulator.
What PT-141 Actually Is
PT-141 is the research name for bremelanotide, a synthetic peptide that activates melanocortin receptors in the brain. Scientists first studied it as a tanning agent, then noticed it affected sexual arousal.
The FDA approved bremelanotide in 2019 as Vyleesi, a self-injected prescription for premenopausal women with hypoactive sexual desire disorder (HSDD). It is not approved for men, and it is not approved in pill or capsule form for anyone.
Why Capsules Are Not the Approved Form
Peptides are fragile molecules. Swallowed, they pass through stomach acid and digestive enzymes that break them apart before much of the drug reaches the bloodstream.
That is why bremelanotide was developed as an injection. A subcutaneous dose bypasses the gut and delivers a reliable amount into circulation.
Nasal formulations have also been tested in clinical trials, which is why searches for pt-141 peptide nasal spray remain common, but absorption through the nasal lining is still less predictable than an injection.
- Injection: predictable absorption and the only FDA-approved route.
- Nasal spray: studied in trials, variable absorption, not FDA-approved.
- Capsules: no approved product, unverified potency, unverified purity.
Delivery Methods Compared
| Delivery form | Regulatory status | Absorption | Typical reported research dose |
|---|---|---|---|
| Subcutaneous injection (Vyleesi) | FDA-approved for premenopausal women with HSDD | Reliable and predictable | 1.75 mg per dose |
| Nasal spray | Not approved; studied in trials | Variable | Higher doses used in early studies |
| Oral capsule | Not approved; sold as a research chemical | Poor; broken down in the digestive tract | No validated human dose |
Reported Dosing and the Limits of Oral Data
Because no oral product is approved, there is no standard capsule dose. Published trials used injected doses of 1.75 mg, and some early nasal studies used higher amounts.
Online sellers sometimes publish a pt-141 peptide dosage chart listing oral amounts from 5 mg to 20 mg. Those numbers are not supported by controlled human trials of oral bremelanotide.
Searching for guidance is understandable, but no regulatory body has issued dosing guidance for men or for oral use.
Cost, Sourcing, and Legal Gray Areas
In the U.S., PT-141 capsules are usually sold as "not for human consumption" research chemicals. That label is a legal workaround rather than a safety guarantee.
The pt-141 peptide price varies widely. Research vials and capsules often run $30 to $100 per unit, while telehealth or compounding options usually cost more. Overseas sellers may be cheaper but carry customs and quality risks.
Side Effects and Safety
Reported side effects of bremelanotide include nausea, flushing, headache, and vomiting. Nausea is the most common reason people stop using it.
Bremelanotide can also raise blood pressure temporarily, so people with uncontrolled hypertension or heart disease should avoid it. Combining it with blood pressure medication, MAOIs, or other prescriptions can add risk.
PT-141 peptide capsules are not FDA-approved for human use in the United States, so any oral product carries unknown risks, including contamination, inaccurate dosing, and unlisted ingredients.
Talk with a licensed healthcare professional before using any peptide product, and do not start or stop prescription medication without medical advice.
Who Should Avoid Bremelanotide
- People with uncontrolled high blood pressure or known cardiovascular disease.
- Anyone taking MAOIs or other interacting prescriptions.
- People who are pregnant or breastfeeding.
- Anyone hoping to use an unverified oral capsule in place of medical care.
What User Reviews Can and Cannot Tell You
Forums and vendor pages are full of pt-141 peptide reviews, and reported results range from strong effects to nothing at all. That inconsistency is expected when the product itself may contain little or no active peptide.
Interest in pt-141 peptide for men is high, but the clinical evidence base does not cover male use in the way it covers premenopausal women with HSDD. Anecdotes are not substitutes for controlled data.
The Bottom Line
Bremelanotide has real clinical evidence behind it, but only as an injected prescription for a specific group of patients.
PT-141 peptide capsules exist in a gray market with no FDA oversight, no standard dose, and no guarantee of what is inside the capsule. If you are dealing with low sexual desire, a physician can help you evaluate approved options and safer alternatives.
Frequently Asked Questions
Are PT-141 peptide capsules FDA-approved?
No. The only FDA-approved form of bremelanotide is Vyleesi, a subcutaneous injection approved for premenopausal women with hypoactive sexual desire disorder. Oral capsules sold online are marketed as research chemicals and have not been reviewed for safety, purity, or effectiveness.
Do PT-141 capsules work the same as the injection?
Most likely not. Peptides are broken down by stomach acid and digestive enzymes, so oral bremelanotide absorption is poor and unpredictable. Injectable bremelanotide bypasses the digestive tract and delivers a consistent dose, which is why injection is the approved route.
Can you legally buy PT-141 capsules in the United States?
PT-141 capsules are typically sold as \"not for human consumption\" research chemicals, and selling them as a drug for human use without FDA approval is illegal. Major retailers such as Amazon do not carry PT-141, and no pharmacy stocks an oral version. A prescription for injectable Vyleesi is the only legal path for human use.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.